Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study
Authors
Keywords
Bisphosphonates, Epidemiology, Hip fracture, Mortality, Osteoporosis, Refracture
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 1, Pages 387-396
Publisher
Springer Nature
Online
2015-11-17
DOI
10.1007/s00198-015-3415-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
- (2015) Carmen Criscitiello et al. CANCER TREATMENT REVIEWS
- Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
- (2015) Dae Hyun Kim et al. PLoS One
- Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis
- (2014) Erik F. Eriksen et al. BONE
- Mortality After Hip Fracture in Austria 2008–2011
- (2014) Wolfgang Brozek et al. CALCIFIED TISSUE INTERNATIONAL
- Risk Analysis for Second Hip Fracture in Patients After Hip Fracture Surgery: A Nationwide Population-Based Study
- (2014) Shih-Hsun Shen et al. Journal of the American Medical Directors Association
- Treatment of post-menopausal osteoporosis: beyond bisphosphonates
- (2014) S. Ishtiaq et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Intravenous Treatment With Ibandronate Normalizes Bone Matrix Mineralization and Reduces Cortical Porosity After Two Years in Male Osteoporosis: A Paired Biopsy Study
- (2013) Barbara M Misof et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate use and subsequent hip fracture in South Korea
- (2013) Y.-K. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells
- (2012) R. Thaler et al. BIOCHEMICAL PHARMACOLOGY
- Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study
- (2012) Sandra Maria Alves et al. BONE
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry
- (2012) Y.-K. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study
- (2012) L. Bondo et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
- (2011) Jacqueline R. Center et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
- (2011) William H. Shrank et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Bisphosphonates for post-menopausal osteoporosis: are they all the same?
- (2011) R. Rizzoli QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The Role of Falls in Fracture Prediction
- (2011) Heike A. Bischoff-Ferrari Current Osteoporosis Reports
- Alternative Use of Bisphosphonate Therapy for Rheumatic Disease
- (2010) B. Le Goff et al. CURRENT PHARMACEUTICAL DESIGN
- Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis
- (2010) Jean-Yves Reginster DRUGS
- Epidemiology of hip fracture: Worldwide geographic variation
- (2010) DineshK Dhanwal et al. Indian Journal of Orthopaedics
- Age-specific incidence of first and second fractures of the hip
- (2010) T. M. Lawrence et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
- (2010) Mark J. Bolland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral bisphosphonates are associated with reduced mortality after hip fracture
- (2010) L. A. Beaupre et al. OSTEOPOROSIS INTERNATIONAL
- Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
- (2010) P. N. Sambrook et al. OSTEOPOROSIS INTERNATIONAL
- Epidemiology of hip fractures in Austria: evidence for a change in the secular trend
- (2010) H. P. Dimai et al. OSTEOPOROSIS INTERNATIONAL
- Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates
- (2010) Jeri W. Nieves et al. Current Osteoporosis Reports
- Trends in hip fracture epidemiology in Australia: Possible impact of bisphosphonates and hormone replacement therapy
- (2009) A.A. Fisher et al. BONE
- Incidence and Mortality of Hip Fractures in the United States
- (2009) Carmen A. Brauer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977–2001
- (2009) Jesper Ryg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture
- (2009) Cathleen S Colón-Emeric et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality following hip fracture: Trends and geographical variations over the last 40 years
- (2008) S. Haleem et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study
- (2008) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More